Revolution Medicines, Inc. ($RVMD)
Mancini Anthony โ Chief Global Commercialization Officer
Shares
810
Price
$0.00
Total Value
$0.00
Nearby Earnings
Nov 4, 2026
EPS:Est: -2.34
Revenue:Est: $23.74M
Transaction Details
| Insider | Mancini Anthony |
|---|---|
| Title | Chief Global Commercialization Officer |
| Transaction Date | Nov 9, 2026 |
| Expiration Date | Apr 1, 2035 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Nov 12, 2026 |
| Shares Purchased | 810 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 90,505 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-458844 |
| Document | View SEC Filing |